Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! Download free report on life science investment in China.

CRO/CMO Services

The following articles are focused on China Contract Research Organizations (CROs) and Contract Manfacturing Organizations (CMOs) offering both clinical and pre-clinical services.  Included are news, deals and company information.

Bellen of Beijing Raises $38 Million to Support CRO Operations
Germany's Merck Opens Biologics CRO/CMO in Shanghai
HitGen to Discover Lead Molecules for Takeda
WuXi NextCODE, a Genomics CRO, Closes $240 Million Series B Round
3SBio Acquires CDMO Business from Canada's Therapure for $290 Million
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China